Publication: Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report.
Loading...
Identifiers
Date
2022
Authors
Molera, Cristina
Sarishvili, Tinatin
Nascimento, Andrés
Rtskhiladze, Irakli
Muñoz Bartolo, Gema
Fernández Cebrián, Santiago
Valverde Fernández, Justo
Muñoz Cabello, Beatriz
Graham, Robert J
Miller, Weston
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
X-linked myotubular myopathy (XLMTM) is a rare, life-threatening congenital myopathy characterized by profound skeletal muscle weakness, respiratory distress, and motor dysfunction. However, pathology is not limited to muscle and can be associated with life-threatening hepatic peliosis. Hepatobiliary disease has been reported in up to 17% of XLMTM patients but has not been extensively characterized. We report on five XLMTM patients who experienced intrahepatic cholestasis in their disease natural history, illustrating the need to further investigate these manifestations. These patients shared presentations that included pruritus, hypertransaminemia, and hyperbilirubinemia with normal gamma-glutamyl transferase, following infection or vaccination. Three patients who had genetic testing showed no evidence of genetic mutations associated with familial cholestasis. In one patient, progression to cirrhotic, decompensated liver disease occurred. Further investigations into the molecular pathomechanism underpinning these clinical observations in XLMTM patients will be important for informing patient care.
Description
MeSH Terms
Biopsy
Cholestasis, Intrahepatic
Fatal Outcome
Humans
Infant
Male
Myopathies, Structural, Congenital
Cholestasis, Intrahepatic
Fatal Outcome
Humans
Infant
Male
Myopathies, Structural, Congenital
DeCS Terms
CIE Terms
Keywords
X-linked myotubular myopathy, hepatobiliary disease, intrahepatic cholestasis, liver abnormalities, myotubularin